| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/16/2002 | WO2001029255A3 Diagnostic test for cephalic pain |
| 05/16/2002 | WO2001029235A3 Tms1 compositions and methods of use |
| 05/16/2002 | WO2001027294A9 Virus coat protein/receptor chimeras and methods of use |
| 05/16/2002 | WO2001023428A3 Interleukin-2 receptor associated polypeptides |
| 05/16/2002 | US20020059663 Nucleotide sequences for use in generation of transgenic plant; for use in screening fungicides and insecticides |
| 05/16/2002 | US20020059662 Transgenic eukaryotic cell for use in generation drought, stress, freeze and heat resistant plant |
| 05/16/2002 | US20020059660 Expression vector for use in the generation of disease resistant plants |
| 05/16/2002 | US20020059654 pCAR and its uses |
| 05/16/2002 | US20020059653 Modulating protein complex formation in cells; obtain sample tissue, incubate with acetylcholine esterase, expose to modulator, monitor sample for complex formation |
| 05/16/2002 | US20020059652 Detecting modulators of liver cell propagation, cell differentiation and lymphocyte activity; obtain modulator, incubate with indicator, mix with culture monitor culture for adjustment in activity |
| 05/16/2002 | US20020058801 Nucleotide sequences coding polypeptide for use in treating fragile-x syndrome |
| 05/16/2002 | US20020058800 Compositions and methods for the diagnosis and treatment of immune disorders |
| 05/16/2002 | US20020058798 Antibodies for use in the treatment of tumors |
| 05/16/2002 | US20020058797 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein |
| 05/16/2002 | US20020058796 defl |
| 05/16/2002 | US20020058792 Method for solubilization and naturation of somatotropins |
| 05/16/2002 | US20020058791 Hybrid cytokine of IL-7 and beta-chain of hepatocyte growth factor |
| 05/16/2002 | US20020058790 Nucleotide sequences coding protein for use in the detection, and screening of bactericides |
| 05/16/2002 | US20020058789 Polypeptide for use as tool in the diagnosis of microorganism infections |
| 05/16/2002 | US20020058787 Mhc binding peptide oligomers and methods of use |
| 05/16/2002 | US20020058786 Clarification of protein precipitate suspensions using anionic polymeric flocculants |
| 05/16/2002 | US20020058783 Nucleotide sequences which code polypeptide for use as a wound healing agent; for preventing neuronal damage of stroke; for preventing skin aging |
| 05/16/2002 | US20020058627 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
| 05/16/2002 | US20020058625 Method for purifying factor vWF-complex by means of cation exchange chromatography |
| 05/16/2002 | US20020058623 Addition of cysteine delays the temporal decrease in the effective concentration of the protein. The process is suitable for use in the production of heterologous proteins in microorganisms. |
| 05/16/2002 | US20020058620 Cell growth regulation system |
| 05/16/2002 | US20020058619 Ligand for vascular endothelial growth factor receptor |
| 05/16/2002 | US20020058617 Effective for reducing body mass and for treating obesity-related diseases and disorderssuch as hyperlipidemias, atherosclerosis, diabetes, and hypertension. |
| 05/16/2002 | US20020058614 Especially administered by direct injection into the afflicted cartilagenous region or joint. |
| 05/16/2002 | US20020058613 Modulating the expression or bioactivity of a bcl family member in a neural cell such that axonal growth occurs. |
| 05/16/2002 | US20020058610 DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques; inhibiting such polypeptide for preventing and/or treating neoplasia; diagnostic assays |
| 05/16/2002 | US20020058607 Containing the amino acid sequence (G/S/A/E)-L-F-(F/I/L); each - is a peptide bond, each parenthesis encloses amino acids which are alternatives to one other, and each slash separating the alternative amino acids. |
| 05/16/2002 | US20020058336 Controlling cell binding; obtain target cell, incubate with substrate, monitor cell binding |
| 05/16/2002 | US20020058335 Compositions isolated from stromal cells and methods for their use |
| 05/16/2002 | US20020058334 Cells, genetically modified with optical marker |
| 05/16/2002 | US20020058328 Polypeptide for use in treatment of infections, pain, cancers, diabetes, asthma, eating, psychogical, nevrous system and cardiovascular disoreder, stroke, ulcers, allergies, migraine, vomiting and dyskinesias |
| 05/16/2002 | US20020058326 Microorganism for use in the diagnsis of cancer and treatment of lactase defect |
| 05/16/2002 | US20020058323 Monkey urotensin II |
| 05/16/2002 | US20020058314 DNA coding for protein which confers on bacterium escherichia coli resistance to L-homoserine, and method for producing L-amino acids |
| 05/16/2002 | US20020058312 Plasmid for use in the the treatment and prevention of viral disease |
| 05/16/2002 | US20020058311 Genetically engineered dietetic protein for use in treatment of diabetes, atherosclerosis, hypertension and eating disorders |
| 05/16/2002 | US20020058310 Lectin ss3939 DNA and polypeptides |
| 05/16/2002 | US20020058309 Nucleotide sequences for use in the treatment of nervous system disorders and neuronal damage |
| 05/16/2002 | US20020058308 Polypeptide for use in screening for bactericides |
| 05/16/2002 | US20020058307 Nucleotide sequences coding preferential polypeptides; for use in diagnosis and treatment of infection, cancer, autoimmune diseases, allergies, blood disorders, crohn's disease, sepsis and psoriasis |
| 05/16/2002 | US20020058306 Nucleotide sequences coding preferential protein for use in the diagnosis and treatment of brain and psychological disorders |
| 05/16/2002 | US20020058305 Enzymatic polypeptide for use in diagnosis of skin disorders |
| 05/16/2002 | US20020058297 Microorganism for use as model in screening microbiocides and bactericides |
| 05/16/2002 | US20020058293 Nucleotide sequences coding microorganismal protein; for use in the prevention of preferential microorganismal infection |
| 05/16/2002 | US20020058292 Ovarian tumor antigen and methods of use therefor |
| 05/16/2002 | US20020058290 Stable genetically engineered muscle cell; for use in the generation of modulators for treatment of cancer, metabolic defects, cachexia and aging defects |
| 05/16/2002 | US20020058288 Compound for use in the detection and prevention of parasitic infection of humans |
| 05/16/2002 | US20020058277 Nucleotide sequences which code for the Gap2 protein |
| 05/16/2002 | US20020058276 Proteins related to schizophrenia and uses thereof |
| 05/16/2002 | US20020058275 Adjustment of defective fitting nucleotide sequences; obtain nucleotide sequence samples, incubate dimer binding protein, monitor sample for bound complexes |
| 05/16/2002 | US20020058274 Rapidly degrading GFP-fusion proteins and methods of use |
| 05/16/2002 | US20020058267 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 05/16/2002 | US20020058264 Human regulatory molecules |
| 05/16/2002 | US20020058259 Regulation of human lipoxin A4 receptor-like protein |
| 05/16/2002 | US20020058257 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 05/16/2002 | US20020058253 High affinity TCR proteins and methods |
| 05/16/2002 | US20020058247 Synthetic peptides that bind to the hepatitis B virus core and e antigens |
| 05/16/2002 | US20020058241 Antibody for use in the treatment of prostate cancer |
| 05/16/2002 | US20020058042 Non-IgA fc binding forms of the Group B streptococcal beta antigens |
| 05/16/2002 | US20020058041 Kidney-specific tumor vaccine directed against kidney tumor antigen G-250 |
| 05/16/2002 | US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 05/16/2002 | US20020058037 Use of anti-gp-39 antibodies for treatment and/or reversal of lupus and lupus associated kidney disease |
| 05/16/2002 | US20020058036 Novel fibroblast growth factor and nucleic acids encoding same |
| 05/16/2002 | US20020058032 Compound having a log P (P denotes a partition coefficient in an octanol-water system) value of not less than 2.50 as immobilized on a water-insoluble carrier. |
| 05/16/2002 | US20020058027 C1 bacteriophage lytic system |
| 05/16/2002 | US20020058024 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 05/16/2002 | US20020058022 Novel compounds |
| 05/16/2002 | US20020058020 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 05/16/2002 | US20020058018 Isolated from a cDNA library of fetal liver-spleen tissue |
| 05/16/2002 | DE10054639A1 Spezifischer Co-Aktivator für humane nukleäre Rezeptoren Specific co-activator for human nuclear receptors |
| 05/16/2002 | DE10054303A1 Analoga, Agonisten, Antagonisten und Varianten der Oxidoreduktase-Enzymaktivität des Makrophagen-Migrations-Inhibitions-Faktors (MIF) als Immunmodulatoren, Therapeutika, Diagnostika und Screening-Agenzien bei inflammatorischen und Immunerkrankungen Analogues, agonists, antagonists, and variants of the oxidoreductase enzyme activity of macrophage migration inhibitory factor (MIF) as immunomodulators, therapeutic agents, diagnostic and screening agents in inflammatory and immune diseases |
| 05/16/2002 | DE10046932A1 Expression system for increased production of copper-dependent enzymes, particularly laccase, includes the gene for a copper homeostasis protein |
| 05/16/2002 | CA2431997A1 Method of identifying antibacterial compounds |
| 05/16/2002 | CA2429000A1 Adjuvant combination formulations |
| 05/16/2002 | CA2428543A1 Methods of screening for ltrpc2 modulators |
| 05/16/2002 | CA2428453A1 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | CA2428242A1 Human tumor necrosis factor receptor |
| 05/16/2002 | CA2428241A1 Novel human potassium channel beta subunit |
| 05/16/2002 | CA2428146A1 A plant development regulating gene and its uses |
| 05/16/2002 | CA2428140A1 Secreted proteins |
| 05/16/2002 | CA2428114A1 Apolipoprotein analogues |
| 05/16/2002 | CA2428055A1 Process for the preparation of latent antithrombin iii |
| 05/16/2002 | CA2427825A1 Putrescine-n-methyltransferase promoter |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2426035A1 Streptavidin-binding peptides and uses thereof |
| 05/16/2002 | CA2426030A1 Methods of treating disorders related to apoe |
| 05/16/2002 | CA2425980A1 Foggy |
| 05/16/2002 | CA2399276A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/15/2002 | EP1205553A1 Nucleotide sequences encoding the sigD gene |
| 05/15/2002 | EP1205552A1 Virulence of streptococci, involving ORFs from Streptococcus suis |
| 05/15/2002 | EP1205551A1 Growth hormone and growth hormone releasing hormone compositions |
| 05/15/2002 | EP1205550A1 Polypeptides and nucleic acids encoding the same |
| 05/15/2002 | EP1205549A1 Gene expressed specifically in human fetal heart muscle |
| 05/15/2002 | EP1205547A2 DNA mutagenesis by random fragmentation and reassembly |
| 05/15/2002 | EP1205546A1 Polypeptide and nucleic acids encoding the same |